Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
about
Regulation of glycogen synthase kinase-3 during bipolar mania treatmentTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderGlycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsReview of pharmacological treatment in mood disorders and future directions for drug development.Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disordersCellular plasticity cascades in the pathophysiology and treatment of bipolar disorderGlycogen synthase kinase-3 in the etiology and treatment of mood disorders.Is glycogen synthase kinase-3 a central modulator in mood regulation?Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.GSK3 is a regulator of RAR-mediated differentiationDoes lithium prevent Alzheimer's disease?Potential mechanisms of action of lithium in bipolar disorder. Current understanding.Assessment of circadian function in fibroblasts of patients with bipolar disorder.Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactionsGlycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in miceCa²⁺ influx-linked protein kinase C activity regulates the β-catenin localization, micromere induction signalling and the oral-aboral axis formation in early sea urchin embryosThe wnt pathway in mood disordersPossible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform.Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders.Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer.Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseasesReview of lithium effects on immune cells.AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective study.Chromosome territory relocation during DNA repair requires nuclear myosin 1 recruitment to chromatin mediated by ϒ-H2AX signaling.Inhibition of GSK3 by lithium, from single molecules to signaling networks.Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling.K(v) 7 (KCNQ) channel openers normalize central 2-deoxyglucose uptake in a mouse model of mania and increase prefrontal cortical and hippocampal serine-9 phosphorylation levels of GSK3β.Higher proportion of inactive Gsk3β in platelets of elderly patients with bipolar disorder: an effect of treatment?Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder.Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?Whether lithium inhibits glycogen synthase kinase (GSK)-3β activity in vivo in humans is still an open question.
P2860
Q24594534-44F724AC-45ED-445C-B7CA-0CBCFC445C57Q24626017-5BB92F86-28C5-4311-99F2-56FF12EDE88EQ24685475-818AF348-CAC4-4FB1-9CB3-1EC21EACE349Q26853509-74DCDA11-A141-4983-9943-22522774B66BQ27027115-6979F9D8-F533-40B0-BD47-3E70829A7FCCQ28251880-BC1C18F9-FC76-4E55-87E2-BC6BB9097A05Q30474415-445D9CC1-6948-400E-9E3F-D66CF1973DF1Q30475816-F4FC4B19-8F72-458F-8DD0-1C4BF16BDC55Q30495108-E9475D24-3CF5-44F3-938F-5B989942E8DFQ34119834-CDCA5A14-840B-4B53-891E-1883ED47F949Q34268138-59E588B4-E096-4CC7-A4EE-696696E7D7D4Q34325612-8F0E700C-6CA8-4EDA-A89C-CF9D5C7F8C5CQ34755758-49ED3049-511A-4826-9178-BACD9DF4D85AQ35049564-EC2BC981-DA87-4A96-8A47-289F01C5BD2EQ35187043-2C72FAA6-C084-404B-9BBC-5587D74D3B64Q35559638-72302AC3-E416-4307-A60B-4A2EE9D4994AQ36310513-39CDDE2F-D88D-4AC7-B0A8-4BDFDCA7D072Q36408114-E079E654-B141-479B-855D-E8C7F5C870C0Q36769080-7AC873FE-8376-40D2-A8FC-DBE67F1B1256Q37139199-AAEC965A-3036-45BF-B67A-19AD36CF77FAQ37679609-B0F556A9-4658-46BB-AA3D-D7438119386EQ38266162-044A8FF2-0898-46DD-8BDB-D5A1917A69AFQ38272835-A10A1245-A7CB-4B34-8E3B-89D6487F6E56Q38307464-7C263E3D-E362-4A7D-82B6-95B0D59E7A78Q39194419-C95815BB-DFB8-4186-B597-CEBBE3AD3B1FQ39584289-14C73349-92F5-42AA-8437-4D24CADC261EQ39668647-1A2F14DC-FA98-4B18-804F-15B61F7895E1Q41220276-35B37C25-B704-4981-A3FA-BEA3253CA941Q41285005-B4EC4912-5A7E-4593-8530-EDC2B41F3F91Q41774912-7D748292-D38A-4ACE-8EE2-43D6831E6FEEQ42637406-B807366D-E3D7-48D7-BF8C-ACAC976CA016Q44591494-08BA2EED-AFE5-45EA-AFC1-6996AFBA69D3Q46807738-EAFE5146-E519-4CE3-8930-7C14BB28B1AAQ48912689-F9D130AB-D492-42E6-A791-807FF936289CQ54183701-2C63F1EF-ABC9-4BA5-9C57-384874F6025D
P2860
Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Lithium regulates glycogen syn ...... treatment of bipolar disorder.
@ast
Lithium regulates glycogen syn ...... treatment of bipolar disorder.
@en
type
label
Lithium regulates glycogen syn ...... treatment of bipolar disorder.
@ast
Lithium regulates glycogen syn ...... treatment of bipolar disorder.
@en
prefLabel
Lithium regulates glycogen syn ...... treatment of bipolar disorder.
@ast
Lithium regulates glycogen syn ...... treatment of bipolar disorder.
@en
P2093
P2860
P1476
Lithium regulates glycogen syn ...... treatment of bipolar disorder
@en
P2093
Lori L Davis
Richard S Jope
Roberta S May
Sherer Boswell
Xiaohua Li
P2860
P304
P356
10.1016/J.BIOPSYCH.2006.02.027
P407
P577
2006-06-27T00:00:00Z